If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
41
|
38
|
839
|
138
|
234
|
3
|
1272
|
Gene and significance breakdown #
Total genes and gene combinations: 12
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
FBN1
|
26
|
19
|
306
|
64
|
75
|
3
|
485
|
ADAMTS17
|
5
|
6
|
230
|
34
|
95
|
0 |
365
|
LTBP2
|
1
|
1
|
180
|
16
|
36
|
0 |
231
|
ADAMTS10
|
8
|
10
|
97
|
20
|
21
|
0 |
153
|
FBN1, LOC126862124
|
0 |
0 |
10
|
2
|
3
|
0 |
13
|
FBN1, LOC130057020
|
0 |
0 |
6
|
0 |
1
|
0 |
7
|
ADAMTS17, LOC130058037
|
1
|
0 |
3
|
0 |
1
|
0 |
5
|
FBN1, LOC113939944
|
0 |
0 |
2
|
1
|
1
|
0 |
4
|
FBN1, LOC130057019
|
0 |
0 |
2
|
1
|
1
|
0 |
4
|
ADAMTS10, LOC130063441
|
0 |
0 |
3
|
0 |
0 |
0 |
3
|
ADAMTS17, LOC113939942, LOC126862248
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
FBN1, LOC113939944, LOC126862125
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
Illumina Laboratory Services, Illumina
|
0 |
0 |
575
|
105
|
219
|
0 |
898
|
Fulgent Genetics, Fulgent Genetics
|
13
|
10
|
229
|
20
|
3
|
0 |
275
|
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
|
9
|
7
|
46
|
6
|
1
|
0 |
69
|
Genome-Nilou Lab
|
0 |
0 |
0 |
0 |
26
|
0 |
26
|
Laboratory of Molecular and Physiopathological Bases of Osteochondrodysplasia, Imagine Institute
|
3
|
17
|
1
|
0 |
0 |
0 |
21
|
OMIM
|
14
|
0 |
0 |
0 |
0 |
0 |
14
|
3billion
|
2
|
0 |
3
|
8
|
0 |
0 |
13
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
|
0 |
0 |
0 |
0 |
11
|
0 |
11
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
|
2
|
1
|
2
|
1
|
0 |
0 |
6
|
Baylor Genetics
|
0 |
0 |
4
|
0 |
0 |
0 |
4
|
Revvity Omics, Revvity
|
0 |
0 |
3
|
0 |
0 |
0 |
3
|
New York Genome Center
|
0 |
0 |
3
|
0 |
0 |
0 |
3
|
Mendelics
|
0 |
0 |
1
|
0 |
1
|
0 |
2
|
Clinical Genomics Laboratory, Washington University in St. Louis
|
0 |
0 |
2
|
0 |
0 |
0 |
2
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
2
|
2
|
Neuberg Centre For Genomic Medicine, NCGM
|
0 |
0 |
2
|
0 |
0 |
0 |
2
|
Research Laboratory of Ophthalmology and Vision Sciences, West China Hospital, Sichuan University
|
0 |
2
|
0 |
0 |
0 |
0 |
2
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
|
0 |
0 |
0 |
1
|
0 |
0 |
1
|
Elahi Laboratory, University of Tehran
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Shenzhen Institute of Pediatrics, Shenzhen Children's Hospital
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Institute of Human Genetics, University Hospital of Duesseldorf
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Genome Diagnostics Laboratory, Amsterdam University Medical Center
|
0 |
0 |
0 |
0 |
1
|
0 |
1
|
UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Suma Genomics, Suma Genomics
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.